Page not found
We are sorry, but the page you are looking for cannot be found.
Some pages have been moved or renamed. Maybe it is one of these pages you are looking for:
Antimicrobial resistance is a complex issue. The spread of infection between animals, humans and in the environment means that we must move away from isolated interventions in a single sector. ICARS takes a holistic approach to transform evidence to practice.
More information about our strategy.
A unique approch
It is the unique way of working, the “how to?”, that distinguishes ICARS from others in the AMR landscape. Our focus is on LMICs, where tackling AMR sustainably poses a great challenge. ICARS provides a unique value proposition – a funded partnership, collaborating with the country to co-develop evidence-based, context specific, cost-effective and sustainable solutions to combat AMR, advancing each country’s individual NAP.
More information about our unique approach.
Find out more about our team.